Georgia State Menu
Georgia State Menu

Main navigation

Office of Faculty Affairs

Main navigation

Office of Faculty Affairs

Office of Faculty Affairs

WELCOME TO THE OFFICE OF FACULTY AFFAIRS

We believe that great faculty are at the core of a great university. Our office provides supportive infrastructure and programming to recruit, appoint, retain, and support our faculty members and to help them achieve their full potential during their time at Georgia State University.
UNIVERSITY FACTS

We’re ranked No. 2 in the nation, only behind Princeton, for our commitment to teaching.

$319 million economic impact generated by research in fiscal year 2018.

R1 Georgia State ranks among the nation’s top 115 R1 universities in the Carnegie Foundation’s elite category of Highest Research Activity.

$122.7 million total research awards in fiscal year 2018.

The Office of Faculty Affairs provides support in the following areas:

Faculty-related policies and procedures such as those related to appointment, leaves, and promotion and tenure.

Faculty development programs, workshops, and fellowships, many of which are offered through our outstanding Center for Excellence in Teaching and Learning.

Leadership programming for university administrators and department chairs; and management of GSU’s awards process to recognize outstanding faculty through a range of university-wide and system-wide awards.

Whether you are a prospective faculty member considering a future at Georgia State or a current faculty member – tenure-track, non-tenure-track, or part-time – we hope you will spend some time browsing the resources on our site. Please do not hesitate to reach out to us if we can be of any help.

Faculty Highlights

null

The Pandemic Remade Everything — Including Smoking

New research led by associate professor Lucy Popova examines how the COVID-19 pandemic affected tobacco use in America.

null

Can America's Healthcare Crisis Be Solved?

Law professor Erin Fuse Brown studies the many ways in which Americans are ill-served by the nation’s healthcare system. But change could be on the horizon.

 

null

Gilead Sciences Inc. Partners with Center for Translational Antiviral Research to Test Oral Remdesivir Variant

To better reach outpatients early after infection, Gilead Sciences Inc. has partnered with researchers, including Dr. Richard Plemper, senior author of the study, in Georgia State University’s Center for Translational Antiviral Research to test a modified version of remdesivir that can be taken orally.